Work

Table S3 from Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

Year: 2023

Type: other

Abstract: Genotypic status of ALK, TP53, MDM2/4, and MYCN in human neuroblastoma cells used for the DIMSCAN cytotoxicity assay.

DOI: 10.1158/1078-0432.22461545.v1

Authors: Kateryna Krytska, Hannah T. Ryles, Renata Sano, Pichai Raman, Nicole R. Infarinato, Theodore D. Hansel, Monish R. Makena, Michael M. Song, C. Patrick Reynolds, Yael P. Mossé

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361920268

Cites:

Cited by:

Related to: 10